glp-1 receptor agonist type 1 diabetes randomized trial agonists in the treatment of 2 – state-of-the-art The evidence for GLP-1 receptor

The outcomes support the effectiveness, safety and potential of oral GLP-1 therapy, which has become more and more significant in the pharmacologic therapy industry as a convenient, effective, and long-term treatment in obesity

Yoon HS, Cho CH, Yun MS, Jang SJ, You HJ, Kim JH, et al

Mol Metab 2022;63:101533.ArticlePubMedPMC 61

Gestational diabetes mellitus

Aggressive Nature and Treatment Challenges of Youth-Onset T2D Youth-onset T2D progresses rapidly, with early onset of complications in adulthood

The fact is that these products can be sold without a prescription, directly to consumers, to make what is essentially false and misleading claims. Natures Ozempic First approved in 2005 to treat Type 2 diabetes as a twice-daily injection, GLP-1 drugs have exploded in use over the past four years and are now widely available in pill form for weight loss and diabetes